Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
DNA Synthesis Inhibition via DNA Crosslinking (N/A)
- Target
- N/A
- Molecular classification
- DNA, Genomic DNA
01
Overview
Platinum-based chemotherapeutic agents inhibit DNA synthesis by forming DNA crosslinks. These crosslinks disrupt DNA replication and transcription, leading to cell cycle arrest and apoptosis. The effectiveness of platinum agents depends on their ability to induce persistent blocks in replication and transcription through stable DNA adduct formation. Resistance mechanisms involving DNA repair pathways are a significant clinical challenge.
- Other names
- DNA CrosslinkingPlatinum-induced DNA DamageDNA Adduct FormationReplication InhibitionTranscription Inhibition
02
Mechanism of action
Covalent binding of platinum compounds to DNA, forming intra- and interstrand crosslinks that inhibit DNA replication and transcription.
03
Biological functions
DNA ReplicationDNA TranscriptionCell CycleDNA RepairApoptosis
04
Disease associations
Cancer
05
Safety considerations
NephrotoxicityNeurotoxicityMyelosuppressionDrug resistanceSecondary malignancies
06
Interacting drugs
Cisplatin
3 more in the full profile.
07
Biomarkers
DNA repair pathway activity (e.g., NER)Expression levels of DNA repair genes
Beyond the preview
Go deeper on DNA Synthesis Inhibition via DNA Crosslinking (N/A).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on DNA Synthesis Inhibition via DNA Crosslinking (N/A).